Arizona State Retirement System Adverum Biotechnologies, Inc. Transaction History

Arizona State Retirement System

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 04, 2022	SELL	$1.74 - $2.4 $27,850 - $38,414	-16,006 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.08 - $3.6 $224 - $388	108 Added 0.68%	16,006 $35,000
Q2 2021 Aug 02, 2021	SELL	$3.36 - $10.56 $3,790 - $11,911	-1,128 Reduced 6.63%	15,898 $56,000
Q1 2021 May 06, 2021	BUY	$9.26 - $14.36 $4,342 - $6,734	469 Added 2.83%	17,026 $168,000
Q4 2020 Jan 28, 2021	SELL	$9.84 - $14.26 $20,004 - $28,990	-2,033 Reduced 10.94%	16,557 $179,000
Q3 2020 Nov 05, 2020	BUY	$10.3 - $21.64 $52,550 - $110,407	5,102 Added 37.83%	18,590 $191,000
Q2 2020 Aug 04, 2020	SELL	$8.53 - $25.64 $3,642 - $10,948	-427 Reduced 3.07%	13,488 $282,000
Q1 2020 May 05, 2020	BUY	$7.98 - $16.32 $111,041 - $227,092	13,915 New	13,915 $136,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

Stay updated on Arizona State Retirement System with notifications on news.